Sindlev Rene's most recent trade in Renovaro Biosciences Inc was a trade of 62,112 Option to purchase shares of common stock done . Disclosure was reported to the exchange on June 25, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Renovaro Biosciences Inc | Rene Sindlev | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2024 | 62,112 | 62 | - | - | Option to purchase shares of common stock | |
Renovaro Biosciences Inc | Sindlev Rene | Director, Ten Percent Owner | 20 Feb 2024 | 471,699 | 13,605,297 (29%) | 1% | 0.5 | 250,000 | Common Stock | |
Renovaro Biosciences Inc | Rene Sindlev | Director, Ten Percent Owner | 20 Feb 2024 | 471,699 | 471,698 | - | - | Warrant (Right to Buy) | ||
Renovaro Biosciences Inc | Rene Sindlev | Director, Ten Percent Owner | 13 Feb 2024 | 701,260 | 13,133,598 (28%) | 1% | - | Common Stock | ||
Renovaro Biosciences Inc | Rene Sindlev | Director, Ten Percent Owner | 13 Feb 2024 | 70,126 | 0 | - | - | Series A Convertible Preferred Stock | ||
Renovaro Biosciences Inc | Rene Sindlev | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2023 | 131,579 | 131,579 | - | - | Option to purchase shares of Common Stock | |
Renovaro Biosciences Inc | Rene Sindlev | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 1.14 per share. | 17 Mar 2023 | 877,193 | 10,545,544 (22%) | 1% | 1.1 | 1,000,000 | Common Stock |
Renovaro Biosciences Inc | Rene Sindlev | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 438,597 | 438,597 | - | - | Warrant (Right to Buy) | |
Renovaro Biosciences Inc | Rene Sindlev | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2022 | 32,609 | 32,609 | - | - | Option to Purchase Shares of Common Stock | |
Renovaro Biosciences Inc | Rene Sindlev | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 08 Jun 2022 | 128,493 | 0 (0%) | 0% | - | Common Stock | |
Renovaro Biosciences Inc | Rene Sindlev | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 08 Jun 2022 | 125,000 | 0 (0%) | 0% | - | Common Stock | |
Renovaro Biosciences Inc | Rene Sindlev | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2021 | 3,646 | 3,646 | - | - | Option to purchase shares of common stock | |
Renovaro Biosciences Inc | Rene Sindlev | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2021 | 9,036 | 9,036 | - | - | Option to purchase shares of common stock |